Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers
Ample evidence supports the use of statin therapy for secondary prevention in patients with a history of atherosclerotic cardiovascular disease (ASCVD), but evidence is wanting in the case of primary prevention, low-risk individuals, and elderly adults 65+. Statins are effective in lowering low-dens...
Main Authors: | Alyssa M. B. White, Hillary R. Mishcon, John L. Redwanski, Ronald D. Hills |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/11/3748 |
Similar Items
-
Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses
by: Naveen Garg, et al.
Published: (2017-07-01) -
PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01) -
RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01) -
Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
by: Henock G. Yebyo, et al.
Published: (2020-09-01) -
Statins: Not all are benefits
by: Isabel García Cuerda, et al.
Published: (2018-10-01)